硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 GRHL1 抗体对
试剂盒

人 GRHL1 抗体对

01AB01714

Grainyhead like transcription factor 1 (GRHL1) is a highly conserved member of the grainyhead family of transcription factors, essential for epithelial development and the maintenance of the skin barrier. It functions as either a homodimer or a heterodimer with GRHL2 or GRHL3, binding to specific consensus DNA sequences to regulate genes involved in epidermal differentiation and hair anchorage. A key downstream target of GRHL1 is the desmosomal cadherin DSG1, which is critical for the formation of intercellular junctions. Structurally, GRHL1 utilizes an immunoglobulin-like DNA-binding domain to interact with the major and minor grooves of its target promoters. While its primary physiological role is centered on barrier integrity, reduced expression of GRHL1 is associated with epidermal defects that phenocopy the loss of DSG1. It may also play a role in regulating glucose homeostasis and has been implicated in certain cancers where impaired target-site recognition disrupts normal epithelial growth.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
GRHL1
基因别名
LBP32; MGR; TFCP2L2
蛋白别名
grainyhead like transcription factor 1; GRHL1
UniProt
Q9NZI5
物种
Human

产品详情

靶点名称
GRHL1
蛋白名称
grainyhead like transcription factor 1
蛋白别名
Grainyhead-like protein 1 homolog; Mammalian grainyhead; NH32; Transcription factor CP2-like 2; Transcription factor LBP-32
靶点基因名
GRHL1
基因别名
LBP32; MGR; TFCP2L2
UniProt
Q9NZI5
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Grainyhead like transcription factor 1 (GRHL1) is a highly conserved member of the grainyhead family of transcription factors, essential for epithelial development and the maintenance of the skin barrier. It functions as either a homodimer or a heterodimer with GRHL2 or GRHL3, binding to specific consensus DNA sequences to regulate genes involved in epidermal differentiation and hair anchorage. A key downstream target of GRHL1 is the desmosomal cadherin DSG1, which is critical for the formation of intercellular junctions. Structurally, GRHL1 utilizes an immunoglobulin-like DNA-binding domain to interact with the major and minor grooves of its target promoters. While its primary physiological role is centered on barrier integrity, reduced expression of GRHL1 is associated with epidermal defects that phenocopy the loss of DSG1. It may also play a role in regulating glucose homeostasis and has been implicated in certain cancers where impaired target-site recognition disrupts normal epithelial growth.